L'équipe du département de pharmacologie

FIELDS

CONTACT

 

 

 

Université Bordeaux 2 CHU de Bordeaux INSERM
Département Hospitalo-Universitaire de Pharmacologie de Bordeaux
fren
  • Home
  • Publications in 2018

PUBLICATIONS in 2018

Publications' last update : 2018-07-16

  1. Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study
    Br J Clin Pharmacol. 2018 (ahead of print)
    Bénard-Laribière A, Pambrun E, Sutter-Dallay AL, Gautier S, Hurault-Delarue C, Damase-Michel C, Lacroix I, Bégaud B, Pariente A.
     PubMed citation

  2. Use of lipid-lowering drugs and the risk of cataract: a population-based nested case-control study
    Clin Pharmacol Ther. 2018 (ahead of print)
    Bezin J, Mansiaux Y, Noize P, Salvo F, Bégaud B, Pariente A.
     PubMed citation

  3. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
    CNS Drugs. 2018 (ahead of print)
    Billioti de Gage S, Collin C, Le-Tri T, Pariente A, Bégaud B, Verdoux H, Dray-Spira R, Zureik M.
     PubMed citation

  4. Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis
    Oncotarget. 2018 (9-42) 26724-26736
    Calmettes C, Gabriel F, Blanchard E, Servant V, Bouchet S, Kabore N, Forcade E, Leroyer C, Bidet A, Latrabe V, Leguay T, Vigouroux S, Tabrizi R, Breilh D, Accoceberry I, de Lara MT, Pigneux A, Milpied N, Dumas PY.
     PubMed citation

  5. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database
    Fundam Clin Pharmacol. 2018 (ahead of print)
    Cazacu I, Stroe R, Dondera R, Mogosan C, Haramburu F, Fourrier-Réglat A, Loghin F.
     PubMed citation

  6. [Psychoactive substances use in Réunion Island and Mayotte, French departments in Indian Ocean]
    Therapie. 2018 (ahead of print)
    Daveluy A, Haramburu F.
     PubMed citation

  7. Tamper-resistant prescription forms for narcotics in France: should we generalise them?
    Fundam Clin Pharmacol. 2018 (ahead of print)
    Daveluy A, Sauvaget L, Bastien A, Lapeyre-Mestre M, Collin C, Richard N, Haramburu F.
     PubMed citation

  8. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions
    Br J Clin Pharmacol. 2018 (ahead of print)
    Deljehier T, Pariente A, Miremont-Salamé G, Haramburu F, Nguyen L, Rubin S, Rigothier C, Théophile H.
     PubMed citation

  9. The economic burden of preventable adverse drug reactions: a systematic review of observational studies
    Expert Opin Drug Saf. 2018 (ahead of print)
    Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, Ingrasciotta Y, Salvo F, Spina E, Trifirò G.
     PubMed citation

  10. Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors
    Heart. 2018 (ahead of print)
    Grouthier V, Lebrun-Vignes B, Glazer AM, Touraine P, Funck-Brentano C, Pariente A, Courtillot C, Bachelot A, Roden DM, Moslehi JJ, Salem JE.
     PubMed citation

  11. Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
    Eur Respir J. 2018 (ahead of print)
    Humbert M, Taillé C, Mala L, Le Gros V, Just J, Molimard M.
     PubMed citation

  12. Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort
    Eur Arch Psychiatry Clin Neurosci. 2018 (ahead of print)
    Hurault-Delarue C, Lacroix I, Bénard-Laribière A, Montastruc JL, Pariente A, Damase-Michel C.
     PubMed citation

  13. Impact of cancer diagnosis on persistence of oral antidiabetic drugs
    Diabetes Res Clin Pract. 2018 (139) 323-330
    Létinier L, Mansiaux Y, Pariente A, Fourrier-Réglat A.
     PubMed citation

  14. Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study
    Eur Psychiatry. 2018 (52) 85-94
    Llorca PM, Bobes J, Fleischhacker WW, Heres S, Moore N, Bent-Ennakhil N, Sapin C, Loze JY, Nylander AG, Patel MX.
     PubMed citation

  15. Non-communicable diseases in Indian slums: re-framing the Social Determinants of Health
    Glob Health Action. 2018 (11-1)
    Lumagbas LB, Coleman HLS, Bunders J, Pariente A, Belonje A, de Cock Buning T.
     PubMed citation

  16. Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
    Drug Saf. 2018 (ahead of print)
    Maura G, Billionnet C, Coste J, Weill A, Neumann A, Pariente A.
     PubMed citation

  17. High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MS
    J Pharm Biomed Anal. 2018 (150) 112-120
    Merienne C, Rousset M, Ducint D, Castaing N, Titier K, Molimard M, Bouchet S.
     PubMed citation

  18. Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users
    Eur J Clin Pharmacol. 2018 (ahead of print)
    Montastruc F, Bénard-Laribière A, Noize P, Pambrun E, Diaz-Bazin F, Tournier M, Bégaud B, Pariente A.
     PubMed citation

  19. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics
    Postgrad Med. 2018 (130-2) 188-199
    Moore N, Scheiman JM.
     PubMed citation

  20. Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database
    Drug Saf. 2018 (ahead of print)
    Mouchet J, Bégaud B.
     PubMed citation

  21. Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis
    Vaccine. 2018 (ahead of print)
    Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B.
     PubMed citation

  22. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis
    Pharmacol Res. 2018 (ahead of print)
    Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B.
     PubMed citation

  23. [The nocebo effect: Various aspects and consequences in clinical practice]
    Rev Med Interne. 2018 (ahead of print)
    Mouly S, Bergmann JF, Molimard M.
     PubMed citation

  24. Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
    BMC Pharmacol Toxicol. 2018 (19-1) 27
    Opadeyi AO, Fourrier-Réglat A, Isah AO.
     PubMed citation

  25. Detection of drug safety signals from clinical trials data: Role of SUSARs
    Pharmacol Res. 2018 (ahead of print)
    Perez C, Olivier P, Lortal B, Duranton S, Montastruc JL, Colin AL, Toulza E, Becker M, Hamy L, Crepin S, Roussillon C, Gimbert A, Petitpain N, Salvo F.
     PubMed citation

  26. Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
    Nutr Metab Cardiovasc Dis. 2018 (ahead of print)
    Raschi E, Poluzzi E, Salvo F, Pariente A, De Ponti F, Marchesini G, Moretti U.
     PubMed citation

  27. Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
    Clin Colorectal Cancer. 2018 (ahead of print)
    Rouyer M, François E, Cunha AS, Monnereau A, Noize P, Robinson P, Droz-Perroteau C, Le Monies de Sagazan A, Jové J, Lassalle R, Moore N, Fourrier-Réglat A, Smith D; EREBUS Study Group.
     PubMed citation

  28. [Understanding the distrust towards the assessment of medicines. Beyond conflict of interests]
    Therapie. 2018 (ahead of print)
    Tournay V, Pariente A.
     PubMed citation